South Korea
· Delayed Price · Currency is KRW Psomagen Statistics
Total Valuation
Psomagen has a market cap or net worth of KRW 86.37 billion. The enterprise value is 85.51 billion.
| Market Cap | 86.37B |
| Enterprise Value | 85.51B |
Important Dates
The next estimated earnings date is Thursday, November 14, 2024.
| Earnings Date | Nov 14, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Psomagen has 19.24 million shares outstanding. The number of shares has decreased by -0.51% in one year.
| Shares Outstanding | 19.24M |
| Shares Change (YoY) | -0.51% |
| Shares Change (QoQ) | -9.30% |
| Owned by Insiders (%) | 20.31% |
| Owned by Institutions (%) | n/a |
| Float | 8.25M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.43 |
| PB Ratio | 2.75 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -13.90 |
| EV / Sales | 2.51 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -20.16 |
Financial Position
The company has a current ratio of 2.12, with a Debt / Equity ratio of 0.32.
| Current Ratio | 2.12 |
| Quick Ratio | 1.57 |
| Debt / Equity | 0.32 |
| Debt / EBITDA | n/a |
| Debt / FCF | -2.35 |
| Interest Coverage | -26.93 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | 366.34M |
| Profits Per Employee | -66.15M |
| Employee Count | 89 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -17.28% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -17.28% |
| 50-Day Moving Average | 4,614.40 |
| 200-Day Moving Average | 4,789.33 |
| Relative Strength Index (RSI) | 48.54 |
| Average Volume (20 Days) | 164,722 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Psomagen had revenue of KRW 34.07 billion and -6.15 billion in losses. Loss per share was -333.88.
| Revenue | 34.07B |
| Gross Profit | 7.11B |
| Operating Income | -5.90B |
| Pretax Income | -6.44B |
| Net Income | -6.15B |
| EBITDA | -1.49B |
| EBIT | -5.90B |
| Loss Per Share | -333.88 |
Balance Sheet
The company has 10.75 billion in cash and 9.97 billion in debt, giving a net cash position of 783.78 million or 40.75 per share.
| Cash & Cash Equivalents | 10.75B |
| Total Debt | 9.97B |
| Net Cash | 783.78M |
| Net Cash Per Share | 40.75 |
| Equity (Book Value) | 31.32B |
| Book Value Per Share | 1,632.20 |
| Working Capital | 12.21B |
Cash Flow
In the last 12 months, operating cash flow was -224.40 million and capital expenditures -4.02 billion, giving a free cash flow of -4.24 billion.
| Operating Cash Flow | -224.40M |
| Capital Expenditures | -4.02B |
| Free Cash Flow | -4.24B |
| FCF Per Share | -220.51 |
Margins
Gross margin is 20.87%, with operating and profit margins of -17.33% and -18.06%.
| Gross Margin | 20.87% |
| Operating Margin | -17.33% |
| Pretax Margin | -18.91% |
| Profit Margin | -18.06% |
| EBITDA Margin | -4.38% |
| EBIT Margin | -17.33% |
| FCF Margin | -12.45% |
Dividends & Yields
Psomagen does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.51% |
| Shareholder Yield | 0.51% |
| Earnings Yield | -7.44% |
| FCF Yield | -4.91% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Psomagen has an Altman Z-Score of 1.55. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.55 |
| Piotroski F-Score | n/a |